Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma

Cancer Causes and Control

Volumn 21, Issue 1, 2010, Pages 127-133

  Kilfoy, Briseis A ^a,b   Zheng, Tongzhang ^b   Lan, Qing ^a   Han, Xuesong ^b   Holford, Theodore ^b   Hein, David W ^c   Qin, Qin ^d   Leaderer, Brian ^b   Morton, Lindsay M ^a   Yeager, Meredith ^a   Boyle, Peter ^e   Zhao, Ping ^f   Chanock, Stephen ^a   Rothman, Nathaniel ^a   Zhang, Yawei ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY   (United States)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF SOUTHERN MAINE   (United States)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f INSTITUTE OF CANCER RESEARCH   (China)

Author keywords

NAT1; NAT2; Non Hodgkin lymphoma; Single nucleotide polymorphisms; Smoking

Indexed keywords

ACYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE; DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

ADULT; AGED; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; ISOENZYMES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 74149093116     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9442-8     Document Type: Article

References (48)

1. CA Clarke SL Glaser 2002 Changing incidence of non-Hodgkin lymphomas in the United States Cancer 94 7 2015 2023 10.1002/cncr.10403 11932904 (Pubitemid 34270055)
2. F Groves M Linet L Travis SS Devesa 2000 Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995 J Natl Cancer Inst 92 15 1240 1251 10.1093/jnci/92.15.1240 1:STN:280:DC%2BD3cvhsVWrug%3D%3D 10922409
3. LM Morton SS Wang SS Devesa P Hartge DD Weisenburger MS Linet 2006 Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 Blood 107 265 276 10.1182/blood-2005-06-2508 1:CAS:528:DC%2BD28XhsVGlsg%3D%3D 16150940 (Pubitemid 43053551)
4. TR Holford T Zheng ST Mayne LA McKay 1992 Time trends of non-Hodgkin's lymphoma: are they real? What do they mean? Cancer Res 52 19 Suppl 5443s 5446s 1:STN:280:DyaK3s%2Fgsl2jsw%3D%3D 1394151
5. T Zheng ST Mayne P Boyle TR Holford WL Liu J Flannery 1992 Epidemiology of non-Hodgkin lymphoma in Connecticut: 1935-1988 Cancer 70 4 840 849 10.1002/1097-0142(19920815)70:4<840::AID-CNCR2820700420>3.0.CO;2-I 1:STN:280:DyaK38zltl2ruw%3D%3D 1643616
6. MA Eltom A Jemal SM Mbulaiteye SS Devesa RJ Biggar 2002 Trends in Kaposi's sarcoma, non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998 J Natl Cancer Inst 94 16 1204 1210 12189223
7. SG Fisher RI Fisher 2004 The epidemiology of non-Hodgkin's lymphoma Oncogene 23 38 6524 6534 10.1038/sj.onc.1207843 1:CAS:528:DC%2BD2cXmvVOrtbo%3D 15322522 (Review) (Pubitemid 39265515)
8. D Alexander P Mink HO Adami, et al. 2007 The non-Hodgkin lymphomas: a review of the epidemiologic literature Int J Cancer 120 1 39 10.1002/ijc.22719 17405121 (Pubitemid 46732571)
9. N Chiorazzi KR Rai M Ferrarini 2005 Chronic lymphocytic leukemia N Engl J Med 352 8 804 815 10.1056/NEJMra041720 1:CAS:528:DC%2BD2MXhsFCiu74%3D 15728813 (Pubitemid 40271175)
10. Müller AM, Ihorst G, Mertelsmann R, Engelhardt M (2005) Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 84(1):1-12 (Epub 2004 Oct 9; review)
11. GP Pfeifer MF Denissenko M Olivier N Tretyakova SS Hecht P Hainaut 2002 Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers Oncogene 21 48 7435 7451 10.1038/sj.onc.1205803 1:CAS:528: DC%2BD38XnvVelu7s%3D 12379884 (Pubitemid 35305599)
12. E Stagnaro R Tumino S Parodi P Crosignani A Fontana G Masala L Miligi O Nanni V Ramazzotti S Rodella A Senoiri Constantini C Vigano C Vindigni P Vineis 2004 Non-Hodgkin's lymphoma and type of tobacco smoke Cancer Epidemiol Biomarkers Prev 13 3 431 437 15006920
13. S Franceschi D Serraino E Bidoli R Talamini U Tirelli A Carbone C La Vecchia 1989 The epidemiology of non-Hodgkin's lymphoma in the north-east of Italy: a hospital-based case-control study Leuk Res 13 6 465 472 10.1016/0145-2126(89)90168-9 1:STN:280:DyaL1MzmtlGgtw%3D%3D 2770331 (Pubitemid 19206829)
14. C Magnani G Pastore L Luzzatto B Terracini 1990 Parental occupation and other environmental factors in the etiology of leukemias and non-Hodgkin's lymphomas in childhood: a case-control study Tumori 76 5 413 419 1:STN:280:DyaK3M%2FnsFGksw%3D%3D 2256184
15. LM Brown GD Everett R Gibson LF Burmeister LM Schuman A Blair 1992 Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma Cancer Causes Control 3 1 49 55 10.1007/BF00051912 1:STN:280:DyaK387mt12ltg%3D%3D 1536913
16. MS Linet JK McLaughlin AW Hsing S Wacholder HT Co Chien LM Schuman E Bjelke WJ Blot 1992 Is cigarette smoking a risk factor for non-Hodgkin's lymphoma or multiple myeloma? Results from the Lutheran Brotherhood Cohort Study Leuk Res 16 6-7 621 624 10.1016/0145-2126(92)90011-U 1:STN:280: DyaK38zktFOgug%3D%3D 1635380
17. RA Nelson AM Levine G Marks L Bernstein 1997 Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma Br J Cancer 76 11 1532 1537 1:STN:280:DyaK1c%2Fmt1WhtA%3D%3D 9400954
18. E De Stefani P Boffetta J Carzoglio S Mendilaharsu H Deneo-Pellegrini 1998 Tobacco smoking and alcohol drinking as risk factors for stomach cancer: a case-control study in Uruguay Cancer Causes Control 9 3 321 329 10.1023/A:1008829321668 9684712 (Pubitemid 28319024)
19. DS Freedman PE Tolbert R Coates EA Brann CR Kjeldsberg 1998 Relation of cigarette smoking to non-Hodgkin's lymphoma among middle-aged men Am J Epidemiol 148 9 833 841 1:STN:280:DyaK1M%2FhsFKgsA%3D%3D 9801013
20. E Stagnaro V Ramazzotti P Crosignani A Fontana G Masala L Miligi O Nanni M Neri S Rodella AS Costantini R Tumino C Viganò C Vindigni P Vineis 2001 Smoking and hematolymphopoietic malignancies Cancer Causes Control 12 4 325 334 10.1023/A:1011216102871 1:STN:280:DC%2BD38%2Fit1CrtA%3D%3D 11456228 (Pubitemid 32553625)
21. LM Morton P Hartge TR Holford EA Holly BCH Chiu P Vineis E Stagnaro EV Willett S Franceschi C La Vecchia AM Hughes W Cozen S Davis RK Severson L Bernstein ST Mayne FR Dee JR Cerhan T Zheng 2005 Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph) Cancer Epidemiol Biomarkers Prev 14 925 933 10.1158/1055-9965.EPI-04-0693 1:CAS:528:DC%2BD2MXjtFSku7s%3D 15824165 (Pubitemid 40478558)
22. SH Zahm DD Weisenburger FF Holmes KP Cantor A Blair 1997 Tobacco and non-Hodgkin's lymphoma: combined analysis of three case-control studies (United States) Cancer Causes Control 8 2 159 166 10.1023/A:1018412027985 1:STN:280:DyaK2s3nvFyltw%3D%3D 9134239 (Pubitemid 27170370)
23. AS Parker JR Cerhan F Dick J Kemp TM Habermann RB Wallace TA Sellers AR Folsom 2000 Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women Leuk Lymphoma 37 3-4 341 349 1:STN:280:DC%2BD3c3hsVKmuw%3D%3D 10752985
24. P Fabbro-Peray JP Daures JF Rossi 2001 Environmental risk factors for non-Hodgkin's lymphoma: a population-based case-control study in Languedoc-Roussillon, France Cancer Causes Control 12 3 201 212 10.1023/A:1011274922701 1:STN:280:DC%2BD3Mzkt1OhsQ%3D%3D 11405325 (Pubitemid 32515367)
25. JC Schroeder AF Olshan R Baric GA Dent CR Weinberg B Yount JR Cerhan CF Lynch LM Schuman PE Tolbert N Rothman KP Cantor A Blair 2002 A case-control study of tobacco use and other non-occupational risk factors for t(14;18) subtypes of non-Hodgkin's lymphoma (United States) Cancer Causes Control 13 2 159 168 10.1023/A:1014397920185 1:STN:280:DC%2BD383gtlCjsA%3D%3D 11936822 (Pubitemid 34229680)
26. H Besson P Renaudier RM Merrill B Coiffier C Sebban J Fabry C Trepo AJ Sasco 2003 Smoking and non-Hodgkin's lymphoma: a case-control study in the Rhone-Alpes region of France Cancer Causes Control 14 4 381 389 10.1023/A:1023978730962 12846371 (Pubitemid 36735109)
27. LM Morton TR Holford B Leaderer P Boyle SH Zahm Y Zhang S Flynn G Tallini B Zhang PH Owens T Zheng 2003 Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women Br J Cancer 89 11 2087 2092 10.1038/sj.bjc.6601388 1:STN:280:DC%2BD3srmsFKqtA%3D%3D 14647142 (Pubitemid 38030907)
28. EV Willett AG Smith GJ Dovey GJ Morgan J Parker E Roman 2004 Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma Cancer Causes Control 15 8 771 780 10.1023/B:CACO.0000043427.77739.60 15456990 (Pubitemid 39335573)
29. PM Bracci EA Holly 2005 Tobacco use and non-Hodgkin lymphoma: results from a population-based case-control study in the San Francisco Bay Area, California Cancer Causes Control 16 4 333 346 10.1007/s10552-004-4324-6 15953976 (Pubitemid 40897826)
30. LM Morton M Schenk DW Hein S Davis SH Zahm W Cozen JR Cerhan P Hartge R Welch SJ Chanock N Rothman SS Wang 2006 Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma Pharmacogenet Genomics 16 8 537 545 10.1097/01.fpc.0000215071.59836.29 1:CAS:528:DC%2BD28XmvFaktL4%3D 16847422 (Pubitemid 44100198)
31. F Pompeo E Brooke A Kawamura A Mushtaq E Sim 2002 The pharmacogenetics of NAT: structural aspects Pharmacogenomics 3 1 19 30 10.1517/14622416.3.1.19 1:CAS:528:DC%2BD38Xjt1Wrsr8%3D 11966400 (Pubitemid 34285236)
32. DW Nebert RA McKinnon A Puga 1996 Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer DNA Cell Biol 15 4 273 280 10.1089/dna.1996.15.273 1:CAS:528:DyaK28XitlCms7k%3D 8639263 (Review)
33. Y Zhang TR Holford B Leaderer SH Zahm P Boyle LM Morton B Zhang K Zou S Flynn G Tallini PH Owens T Zheng 2004 Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women Cancer Causes Control 15 4 419 428 10.1023/B:CACO.0000027506.55846.5d 15141141 (Pubitemid 38988028)
34. Q Lan T Zheng M Shen Y Zhang SS Wang SH Zahm TR Holford B Leaderer P Boyle S Chanock 2007 Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma Hum Genet 121 2 161 168 10.1007/s00439-006-0288-9 1:CAS:528:DC%2BD2sXivVShu70%3D 17149600 (Epub 2006 Dec 6) (Pubitemid 46404450)
35. BR Packer M Yeager L Burdett R Welch M Beerman L Qi H Sicotte B Staats M Acharya A Crenshaw A Eckert V Puri DS Gerhard SJ Chanock 2006 SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes Nucleic Acids Res 34 Database issue D617 D621 10.1093/nar/gkj151 1:CAS:528:DC%2BD28XisFyltg%3D%3D 16381944
36. DW Hein DM Grant E Sim 2000 Update on consensus arylamine N-acetyltransferase gene nomenclature Pharmacogenetics 10 291 292 10.1097/00008571-200006000-00002 1:CAS:528:DC%2BD3cXksFSqsbo%3D 10862519
37. DW Hein MA Doll AJ Fretland MA Leff SJ Webb GH Xiao US Devanaboyina NA Nangju Y Feng 2000 Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms Cancer Epidemiol Biomarkers Prev 9 1 29 42 1:CAS:528:DC%2BD3cXptVOmtA%3D%3D 10667461
38. DW Hein MA Doll AJ Fretland MA Leff SJ Webb GH Xiao, et al. 2000 Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms Cancer Epidemiol Biomarkers Prev 9 29 42 1:CAS:528: DC%2BD3cXptVOmtA%3D%3D 10667461
39. DW Hein 2006 N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk Oncogene 25 1649 1658 10.1038/sj.onc.1209374 1:CAS:528:DC%2BD28XisFyhtbs%3D 16550165
40. BC Chiu C Kolar SM Gapstur T Lawson JR Anderson DD Weisenburger 2005 Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: a population-based case-control study Br J Haematol 128 5 610 615 10.1111/j.1365-2141.2004.05358.x 1:CAS:528:DC%2BD2MXjtVGqsrg%3D 15725081 (Pubitemid 40343229)
41. MC Lemos FJ Cabrita HA Silva M Vivan F Plácido FJ Regateiro 1999 Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias Carcinogenesis 20 7 1225 1229 10.1093/carcin/20.7.1225 1:CAS:528:DyaK1MXkslGhsr0%3D 10383893 (Pubitemid 29341442)
42. I Kerridge L Lincz F Scorgie D Hickey N Granter A Spencer 2002 Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk Br J Haematol 118 2 477 481 10.1046/j.1365-2141.2002.03606.x 1:CAS:528:DC%2BD38XntVCjurk%3D 12139735 (Pubitemid 34994652)
43. OL van der Hel PH Peeters DW Hein MA Doll DE Grobbee D Kromhout HB Bueno de Mesquita 2003 NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women Pharmacogenetics 13 7 399 407 10.1097/00008571-200307000-00005 12835615 (Pubitemid 36900735)
44. M García-Closas N Malats D Silverman M Dosemeci M Kogevinas DW Hein A Tardón C Serra A Carrato R García-Closas J Lloreta G Castaño-Vinyals M Yeager R Welch S Chanock N Chatterjee S Wacholder C Samanic M Torà F Fernández FX Real N Rothman 2005 NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses Lancet 366 9486 649 659 10.1016/S0140-6736(05)67137-1 16112301 (Pubitemid 41176017)
45. A Risch DM Wallace S Bathers E Sim 1995 Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer Hum Mol Genet 4 2 231 236 10.1093/hmg/4.2.231 1:CAS:528:DyaK2MXjvVagt7c%3D 7757072
46. RJ Delfino C Smith JG West HJ Lin E White SY Liao JS Gim HL Ma J Butler H Anton-Culver 2000 Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype Pharmacogenetics 10 5 461 469 10.1097/00008571-200007000-00009 1:CAS:528:DC%2BD3cXlt1yjs7c%3D 10898115 (Pubitemid 30433579)
47. KM Egan PA Newcomb L Titus-Ernstoff A Trentham-Dietz LI Mignone F Farin DJ Hunter 2003 Association of NAT2 and smoking in relation to breast cancer incidence in a population-based case-control study (United States) Cancer Causes Control 14 1 43 51 10.1023/A:1022517506689 12708724 (Pubitemid 36403268)
48. P Bhatti AJ Sigurdson SS Wang J Chen N Rothman P Hartge AW Bergen MT Landi 2005 Genetic variation and willingness to participate in epidemiologic research: data from three studies Cancer Epidemiol Biomarkers Prev 14 10 2449 2453 10.1158/1055-9965.EPI-05-0463 16214931 (Pubitemid 41437851)